Could Fluvoxamine Dose De-escalation Increase Treatment Compliance Without Sacrificing Efficacy in COVID-19 Patients?

Detalles Bibliográficos
Autores principales: Marcec, Robert, Likic, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9307409/
https://www.ncbi.nlm.nih.gov/pubmed/35869361
http://dx.doi.org/10.1007/s40262-022-01154-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9307409/
https://www.ncbi.nlm.nih.gov/pubmed/35869361
http://dx.doi.org/10.1007/s40262-022-01154-x

Ejemplares similares